Loading...
Long‐acting muscarinic antagonist (LAMA) plus long‐acting beta‐agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD)
BACKGROUND: Three classes of inhaler medications are used to manage chronic obstructive pulmonary disease (COPD): long‐acting beta‐agonists (LABA), long‐acting muscarinic antagonists (LAMA), and inhaled corticosteroids (ICS). When two classes of medications are required, LAMA plus LABA (LAMA+LABA) a...
Na minha lista:
| Udgivet i: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Ltd
2017
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464543/ https://ncbi.nlm.nih.gov/pubmed/28185242 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012066.pub2 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|